Avraham Ben-Tzvi - Feb 26, 2025 Form 4 Insider Report for Cyclacel Pharmaceuticals, Inc. (CYCC)

Role
Director
Signature
/s/ Avraham Ben-Tzvi
Stock symbol
CYCC
Transactions as of
Feb 26, 2025
Transactions value $
$0
Form type
4
Date filed
2/28/2025, 04:47 PM
Previous filing
Jan 8, 2025
Next filing
Oct 8, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYCC Non-Qualified Stock Option (Right to Buy) Award $0 +700K $0.00 700K Feb 26, 2025 Common Stock 700K $0.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 26, 2025 (the "Grant Date"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the "Common Stock") of Cyclacel Pharmaceuticals, Inc. (the "Company") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date.